Dr. Marlise R. Luskin received her MD from the University of Pennsylvania in 2009. She completed residency training in Internal Medicine at Brigham and Women's Hospital, followed by a fellowship in Hematology and Oncology at the University of Pennsylvania where she was Chief Fellow. After serving as Chief Medical Resident at Brigham and Women’s Hospital (2015-2016), she joined the Dana-Farber Cancer Institute as a member of the Adult Leukemia program. Her clinical practice focuses on the treatment of acute leukemias including acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and blastic plasmacytoid dendritic cell neoplasm (BPDCN), as well as chronic leukemias including the myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPNs). Her research interests include development of novel treatment approaches for ALL and understanding predictors of treatment response and clinical outcomes in patients with leukemia. She is also a medical educator and serves as associate program director of the Dana-Farber/Harvard Cancer Center and director of education for the DFCI Adult Leukemia program.